The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia
ABSTRACT Objective: The aim of this study is to analyze the clinical utility and cost of the respiratory virus panel test in the febrile neutropenia (FN) episode in children undergoing chemotherapy. Material and Method: From 2014 to 2018, 180 episodes of FN in 93 children with cancer were retrospect...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rabia Yılmaz
2023-03-01
|
| Series: | Journal of Contemporary Medicine |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2867131 |
| _version_ | 1797860779179900928 |
|---|---|
| author | Hüsamettin Vatansev Prof. Dr. Uğur Arslan Melike Emiroğlu Kübra Ertan Gülsüm Alkan Yavuz Köksal Buket Kara |
| author_facet | Hüsamettin Vatansev Prof. Dr. Uğur Arslan Melike Emiroğlu Kübra Ertan Gülsüm Alkan Yavuz Köksal Buket Kara |
| author_sort | Hüsamettin Vatansev |
| collection | DOAJ |
| description | ABSTRACT
Objective: The aim of this study is to analyze the clinical utility and cost of the respiratory virus panel test in the febrile neutropenia (FN) episode in children undergoing chemotherapy.
Material and Method: From 2014 to 2018, 180 episodes of FN in 93 children with cancer were retrospectively analyzed. The patients were divided into those with (Group A) and without respiratory virus panel (Group B). The demographic and clinical features and cost analysis of the groups A and B were noted.
Results: Of these FN episodes, 46 were in Group A (25.5%) and 134 were in Group B (74.5%). We found positivity in 45 (97.8%) of 46 episodes in Group A. While modification was required in 14 FN episodes (30.4%) in Group A, modification was required in 35 FN episodes (26.1%) in group B. The difference was not statistically significant (p=0.570). In Group A, only 5 (10.8%) were modified according to the respiratory virus panel. The respiratory virus panel prices were $72.43 (interquartile range, $38.8). The ratio of respiratory virus panel cost to the total cost was 9.67% (interquartile range 11.6). The median total cost of group A was $663.18 (interquartile range, 850.1), while that of group B was $596.24 (interquartile range, 723.81). The difference was not statistically significant (p=0.141).
Conclusion: The respiratory virus panel may contribute to the preference of antibiotics by giving rapid results in FN attacks. However, no effect on modification rates was observed, and only a small percentage of patients underwent antibiotic modification according to respiratory virus panel. |
| first_indexed | 2024-04-09T21:51:01Z |
| format | Article |
| id | doaj.art-c3ca14ddf97440ea86b9a2c724a7122c |
| institution | Directory Open Access Journal |
| issn | 2667-7180 |
| language | English |
| last_indexed | 2024-04-09T21:51:01Z |
| publishDate | 2023-03-01 |
| publisher | Rabia Yılmaz |
| record_format | Article |
| series | Journal of Contemporary Medicine |
| spelling | doaj.art-c3ca14ddf97440ea86b9a2c724a7122c2023-03-24T19:43:20ZengRabia YılmazJournal of Contemporary Medicine2667-71802023-03-0113234234610.16899/jcm.12281311809The cost effectiveness of the respiratory virus panel in childhood febrile neutropeniaHüsamettin Vatansev0Prof. Dr. Uğur Arslan1Melike Emiroğlu2Kübra Ertan3Gülsüm Alkan4Yavuz Köksal5Buket Kara6Selcuk University School of Medicine Department of Medical BiochemistrySelcuk University School of Medicine Department of Medical MicrobiologySelcuk University School of Medicine Department of Pediatrics, Division of Pediatric Infectious DiseasesSelcuk University School of Medicine Department of PediatricsSelcuk University School of Medicine Department of Pediatrics, Division of Pediatric Infectious DiseasesSelcuk University School of Medicine Department of Pediatrics, Division of Pediatric Hematology and OncologySelcuk University School of Medicine Department of Pediatrics, Division of Pediatric Hematology and OncologyABSTRACT Objective: The aim of this study is to analyze the clinical utility and cost of the respiratory virus panel test in the febrile neutropenia (FN) episode in children undergoing chemotherapy. Material and Method: From 2014 to 2018, 180 episodes of FN in 93 children with cancer were retrospectively analyzed. The patients were divided into those with (Group A) and without respiratory virus panel (Group B). The demographic and clinical features and cost analysis of the groups A and B were noted. Results: Of these FN episodes, 46 were in Group A (25.5%) and 134 were in Group B (74.5%). We found positivity in 45 (97.8%) of 46 episodes in Group A. While modification was required in 14 FN episodes (30.4%) in Group A, modification was required in 35 FN episodes (26.1%) in group B. The difference was not statistically significant (p=0.570). In Group A, only 5 (10.8%) were modified according to the respiratory virus panel. The respiratory virus panel prices were $72.43 (interquartile range, $38.8). The ratio of respiratory virus panel cost to the total cost was 9.67% (interquartile range 11.6). The median total cost of group A was $663.18 (interquartile range, 850.1), while that of group B was $596.24 (interquartile range, 723.81). The difference was not statistically significant (p=0.141). Conclusion: The respiratory virus panel may contribute to the preference of antibiotics by giving rapid results in FN attacks. However, no effect on modification rates was observed, and only a small percentage of patients underwent antibiotic modification according to respiratory virus panel.https://dergipark.org.tr/tr/download/article-file/2867131febrile neutropeniarespiratory virus panelchildrenfebrile neutropeniarespiratory virus panelchildren |
| spellingShingle | Hüsamettin Vatansev Prof. Dr. Uğur Arslan Melike Emiroğlu Kübra Ertan Gülsüm Alkan Yavuz Köksal Buket Kara The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia Journal of Contemporary Medicine febrile neutropenia respiratory virus panel children febrile neutropenia respiratory virus panel children |
| title | The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| title_full | The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| title_fullStr | The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| title_full_unstemmed | The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| title_short | The cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| title_sort | cost effectiveness of the respiratory virus panel in childhood febrile neutropenia |
| topic | febrile neutropenia respiratory virus panel children febrile neutropenia respiratory virus panel children |
| url | https://dergipark.org.tr/tr/download/article-file/2867131 |
| work_keys_str_mv | AT husamettinvatansev thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT profdrugurarslan thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT melikeemiroglu thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT kubraertan thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT gulsumalkan thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT yavuzkoksal thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT buketkara thecosteffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT husamettinvatansev costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT profdrugurarslan costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT melikeemiroglu costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT kubraertan costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT gulsumalkan costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT yavuzkoksal costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia AT buketkara costeffectivenessoftherespiratoryviruspanelinchildhoodfebrileneutropenia |